{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T05:36:00Z","timestamp":1770960960224,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.cellimm.2024.104836","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T09:38:59Z","timestamp":1715938739000},"page":"104836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Triptolide promotes differentiation of human monocytes into immunosuppressive MDSCs"],"prefix":"10.1016","volume":"401-402","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8504-7403","authenticated-orcid":false,"given":"Haozhou","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoguang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cellimm.2024.104836_b0005","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct Target Ther."},{"issue":"1 Suppl","key":"10.1016\/j.cellimm.2024.104836_b0010","first-page":"s12","article-title":"An overview of immunosuppression in solid organ transplantation","volume":"21","author":"Enderby","year":"2015","journal-title":"Am. J. Manag. Care"},{"issue":"10","key":"10.1016\/j.cellimm.2024.104836_b0015","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nrc3581","article-title":"History of myeloid-derived suppressor cells","volume":"13","author":"Talmadge","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.cellimm.2024.104836_b0020","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.immuni.2019.01.019","article-title":"Emerging principles in myelopoiesis at homeostasis and during infection and inflammation","volume":"50","author":"Schultze","year":"2019","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.cellimm.2024.104836_b0025","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.cellimm.2024.104836_b0030","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001223","article-title":"Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation","volume":"8","author":"Cassetta","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.cellimm.2024.104836_b0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12967-018-1395-9","article-title":"Myeloid-derived suppressor cells in transplantation: The dawn of cell therapy","volume":"16","author":"Zhang","year":"2018","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.cellimm.2024.104836_b0040","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.immuni.2013.02.007","article-title":"Tumor necrosis factor-alpha blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation","volume":"38","author":"Sade-Feldman","year":"2013","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.cellimm.2024.104836_b0045","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/eji.200939486","article-title":"Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development","volume":"39","author":"Greifenberg","year":"2009","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.cellimm.2024.104836_b0050","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4049\/jimmunol.170.1.270","article-title":"IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice","volume":"170","author":"Bronte","year":"2003","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.cellimm.2024.104836_b0055","doi-asserted-by":"crossref","first-page":"7898","DOI":"10.4049\/jimmunol.180.12.7898","article-title":"Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion","volume":"180","author":"Dugast","year":"2008","journal-title":"J. Immunol."},{"issue":"13","key":"10.1016\/j.cellimm.2024.104836_b0060","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1073\/pnas.1719190115","article-title":"Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form","volume":"115","author":"Nelp","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.cellimm.2024.104836_b0065","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1084\/jem.20042028","article-title":"Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers","volume":"201","author":"Bronte","year":"2005","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.cellimm.2024.104836_b0070","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1002\/hep.23202","article-title":"Mechanistic insights into immunomodulation by hepatic stellate cells in mice: A critical role of interferon-gamma signaling","volume":"50","author":"Yang","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cellimm.2024.104836_b0075","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/CIRCULATIONAHA.117.030811","article-title":"Cardioprotective role of myeloid-derived suppressor cells in heart failure","volume":"138","author":"Zhou","year":"2018","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.cellimm.2024.104836_b0080","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3727\/096368910X540621","article-title":"In vivo induction of myeloid suppressor cells and CD4(+)Foxp3(+) T regulatory cells prolongs skin allograft survival in mice","volume":"20","author":"Adeegbe","year":"2011","journal-title":"Cell Transplant."},{"issue":"2","key":"10.1016\/j.cellimm.2024.104836_b0085","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1158\/1535-7163.MCT-12-0425","article-title":"Triptolide inhibits MDM2 and induces apoptosis in acute lymphoblastic leukemia cells through a p53-independent pathway","volume":"12","author":"Huang","year":"2013","journal-title":"Mol. Cancer Ther."},{"issue":"8","key":"10.1016\/j.cellimm.2024.104836_b0090","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00109-016-1398-z","article-title":"TNFalpha-induced M-MDSCs promote transplant immune tolerance via nitric oxide","volume":"94","author":"Yang","year":"2016","journal-title":"J. Mol. Med. (Berl)."},{"key":"10.1016\/j.cellimm.2024.104836_b0095","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3389\/fimmu.2018.00282","article-title":"Dexamethasone-induced myeloid-derived suppressor cells prolong allo cardiac graft survival through iNOS- and glucocorticoid receptor-dependent mechanism","volume":"9","author":"Zhao","year":"2018","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.cellimm.2024.104836_b0100","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1189\/jlb.4RI0515-204R","article-title":"Transcriptional regulation of myeloid-derived suppressor cells","volume":"98","author":"Condamine","year":"2015","journal-title":"J. Leukoc Biol."},{"issue":"1","key":"10.1016\/j.cellimm.2024.104836_b0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","article-title":"Myeloid-derived suppressor cells","volume":"5","author":"Gabrilovich","year":"2017","journal-title":"Cancer Immunol. Res."},{"issue":"3","key":"10.1016\/j.cellimm.2024.104836_b0110","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2125.2012.04221.x","article-title":"Triptolide in the treatment of psoriasis and other immune-mediated inflammatory diseases","volume":"74","author":"Han","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.cellimm.2024.104836_b0115","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ejmech.2019.05.032","article-title":"Triptolide: Medicinal chemistry, chemical biology and clinical progress","volume":"176","author":"Hou","year":"2019","journal-title":"Eur. J. Med. Chem."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000887492400039X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000887492400039X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T19:43:24Z","timestamp":1720554204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000887492400039X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":23,"alternative-id":["S000887492400039X"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2024.104836","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triptolide promotes differentiation of human monocytes into immunosuppressive MDSCs","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2024.104836","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104836"}}